Research Article

Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer

Figure 5

Effects of combination of bezafibrate and GSK126 on CDX tumor volumes. (a) Representative image of bearing tumors of PANC-1 in each experimental group. (b) Representative image of bearing tumors of AsPC-1 in each experimental group. (c) Growth curves of bearing tumors of PANC-1 in each experimental group. (d) Growth curves of bearing tumors of AsPC-1 in each experimental group. The values were expressed as the ( for each group). vs. control; # vs. the GSK126 group.
(a)
(b)
(c)
(d)